{
    "nctId": "NCT02774785",
    "briefTitle": "Does Intra-operative MarginProbe Use Reduce Re-excision Rates?",
    "officialTitle": "Reducing Re-excisions After Breast Conserving Surgery: A Randomized Controlled Trial Comparing the MarginProbe Device in Addition to Standard Operating Procedure Versus Standard Operating Procedure Alone in Preventing Re-excision",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 127,
    "primaryOutcomeMeasure": "To determine if intraoperative margin assessment after excision of a cancer reduces second operations (reexcision or mastectomy), compared to standard surgical practice by 9 months after primary surgery.",
    "eligibilityCriteria": "Inclusion Criteria;\n\n* Women aged 18-90 years with DCIS or Invasive Breast cancer containing DCIS diagnosed histopathologically.\n* Histologically diagnosed DCIS or invasive lobular cancer in core biopsy (B5a or B5b).\n* Tumour size 1.5cm - 4cm and undergoing breast cancer surgery. Written informed consent.\n\nExclusion Criteria;\n\n* Unsuitable for BCS on basis of tumour size (\\<1.5cm or \\>4cm) or stage.\n* Radiotherapy contraindicated.\n* No histopathological evidence of DCIS or invasive lobular cancer.\n* Neoadjuvant chemotherapy.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}